Saturn V Capital Management LLC Portfolio Holdings

Saturn V Capital Management LLC

  • $280 Billion
  • Q3 2024

Saturn V Capital Management LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $280 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $29.9B, Disc Medicine Inc with a value of $25.1B, Vaxcyte, Inc. with a value of $23.4B, Cg Oncology Inc with a value of $19.6B, and Cogent Biosciences, Inc. with a value of $18.5B.

Examining the 13F form we can see an increase of $15.1B in the current position value, from $265B to 280B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $280 Billion
Healthcare: $201 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.61B
$29.9 Billion 10.69% of portfolio
200,285
Q3 2024 Added 76.89%
Disc Medicine Inc
-
$25.1 Billion 8.98% of portfolio
-
Q3 2024 Added 1.58%
$5.13B
$23.4 Billion 8.37% of portfolio
204,987
Q3 2024 Reduced 4.96%
Cg Oncology Inc
-
$19.6 Billion 7.01% of portfolio
-
Q3 2024 New
$516M
$18.5 Billion 6.61% of portfolio
1,712,899
Q3 2024 Added 2.33%
Cargo Therapeutics Inc
-
$18.5 Billion 6.61% of portfolio
-
Q3 2024 Added 16.99%
$4.6B
$17.5 Billion 6.25% of portfolio
331,283
Q3 2024 Added 21.78%
$292M
$15.8 Billion 5.65% of portfolio
874,590
Q3 2024 Added 47.41%
$1.89B
$15.1 Billion 5.39% of portfolio
298,974
Q3 2024 New
$186M
$14.1 Billion 5.04% of portfolio
946,335
Q3 2024 Added 24.36%
$34.5B
$12 Billion 4.28% of portfolio
22,111
Q3 2024 Reduced 65.56%
$740M
$9.66 Billion 3.45% of portfolio
501,978
Q3 2024 Added 19.62%
$247M
$8.75 Billion 3.13% of portfolio
481,127
Q3 2024 New
Abivax Sa
-
$7.47 Billion 2.67% of portfolio
-
Q3 2024 Added 3.23%
$120M
$7.16 Billion 2.56% of portfolio
1,368,810
Q3 2024 Added 20.04%
$1.92B
$6.56 Billion 2.34% of portfolio
131,240
Q3 2024 Reduced 20.35%
Neumora Therapeutics Inc.
-
$5.72 Billion 2.04% of portfolio
-
Q3 2024 Added 11.0%
$2.88B
$5.6 Billion 2.0% of portfolio
109,567
Q3 2024 Reduced 77.16%
$682M
$4.62 Billion 1.65% of portfolio
1,120,409
Q3 2024 Added 0.59%
$12.2B
$2.63 Billion 0.94% of portfolio
37,432
Q3 2024 Reduced 79.04%
$264M
$2 Billion 0.71% of portfolio
195,704
Q3 2024 Reduced 46.74%
Contineum Therapeutics Inc
-
$1.48 Billion 0.53% of portfolio
-
Q3 2024 Added 6.13%
Arrivent Biopharma Inc
-
$1.11 Billion 0.4% of portfolio
-
Q3 2024 New
$815M
$1.05 Billion 0.38% of portfolio
31,529
Q3 2024 Reduced 55.87%

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $280 Billion
  • Prior Value $265 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 4 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email